Epitranscriptomic analysis reveals clinical and molecular signatures in glioblastoma

Abstract This study characterizes the glioblastoma (GB) epitranscriptomic landscape in patient who evolve to progressive disease (PD) or pseudo-progressive disease (psPD). Novel differences in N6-Methyladenosine (m6A) RNA methylation patterns between these groups are identified in the first biopsy....

Full description

Bibliographic Details

Published in:	Acta Neuropathologica Communications
Main Authors:	Glaucia Maria de Mendonça Fernandes, Wesley Wang, Saman Seyed Ahmadian, Daniel Jones, Jing Peng, Pierre Giglio, Monica Venere, José Javier Otero
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Subjects:	Glioblastoma Progression disease Pseudo-progression Novel enhancement Epitranscriptome
Online Access:	https://doi.org/10.1186/s40478-025-01966-5